Mark P. Frissora - Form 4 Filing

This filing details a transaction by Mark P. Frissora, a director at BIOADAPTIVES, INC. On April 1, 2026, Mr. Frissora acquired 4,386 shares of Series D Convertible Preferred Stock as compensation for board services. These shares are convertible into 438,600 shares of common stock, subject to a 4.9% beneficial ownership limitation. The conversion is restricted for six months post-issuance, except in cases of liquidation. Each share of Series D Convertible Preferred Stock carries 100 votes per share on matters presented to stockholders. Mr. Frissora currently holds 66,746 shares of Series D Convertible Preferred Stock post-transaction.